Amy Brady - KeyCorp Chief Information Officer, Executive Officer
KEY Stock | USD 15.81 0.17 1.09% |
Executive
Ms. Amy G. Brady is an Chief Information Officer of the Company. She spent 25 years at Bank of America, where she most recently served as Chief Information Officer, Enterprise Technology and Operations at Bank of America, supporting technology and operations delivery for key enterprise functions. Ms. Brady was an executive officer of KeyCorporationsince 2012. since 2012.
Age | 57 |
Tenure | 12 years |
Address | 127 Public Square, Cleveland, OH, United States, 44114-1306 |
Phone | 216 689 3000 |
Web | https://www.key.com |
KeyCorp Management Efficiency
At this time, KeyCorp's Return On Assets are fairly stable compared to the past year. Return On Equity is likely to rise to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.000041 in 2024. At this time, KeyCorp's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 14 B in 2024, whereas Total Assets are likely to drop slightly above 103.4 B in 2024. KeyCorp's management efficiency ratios could be used to measure how well KeyCorp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Rebecca Markovich | Talis Biomedical Corp | 51 | |
Siegbert Kloos | BioNTech SE | N/A | |
Joy Zhou | Mink Therapeutics | N/A | |
Matthew Busch | Amgen Inc | 50 | |
Sebastian MD | BioNTech SE | N/A | |
Justin Claeys | Amgen Inc | N/A | |
Ana Rodriguez | Dyadic International | N/A | |
Gillian Green | Talis Biomedical Corp | N/A | |
Heather Boussios | Mink Therapeutics | N/A | |
Oliver Hennig | BioNTech SE | N/A | |
Arvind Sood | Amgen Inc | N/A | |
James Ryan | BioNTech SE | 49 | |
Doug BA | Dyadic International | N/A | |
Eva Gunnlaugsdottir | Alvotech | N/A | |
Ping Rawson | Dyadic International | 43 | |
Jill Green | Talis Biomedical Corp | N/A | |
Emily Faucette | Talis Biomedical Corp | N/A | |
Nancy Grygiel | Amgen Inc | 56 | |
Katalin Kariko | BioNTech SE | N/A | |
Tanya Zharov | Alvotech | 57 | |
David MD | Amgen Inc | 61 |
Management Performance
Return On Equity | 0.0686 | |||
Return On Asset | 0.0051 |
KeyCorp Leadership Team
Elected by the shareholders, the KeyCorp's board of directors comprises two types of representatives: KeyCorp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of KeyCorp. The board's role is to monitor KeyCorp's management team and ensure that shareholders' interests are well served. KeyCorp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, KeyCorp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jill Hershey, Senior Director - Government Relations and Advocacy | ||
Alexander Cutler, Lead Independent Director | ||
James Dallas, Independent Director | ||
Vernon Patterson, Executive Relations | ||
Clark JD, Chief Officer | ||
Dennis Devine, Co-President of Key Community Bank - Consumer and Bus. Banking and Member Executive Council | ||
H Dallas, Independent Director | ||
Katrina Evans, Chief Center | ||
Joseph Carrabba, Independent Director | ||
Devina Rankin, Independent Director | ||
Kathleen Terrell, Chief Human Resource Officer, Executive Officer | ||
Elizabeth Gile, Independent Director | ||
Christopher Gorman, Chairman of Keybank National Association, CEO of Keybank National Association and President of Key Corporate Bank | ||
Angela Mago, Head of Commercial Bank, Executive Officer | ||
L Waters, General Counsel, Corporate Secretary | ||
David Wilson, Independent Director | ||
Greg Jones, Chief Diversity, Equity, and Inclusion Officer | ||
Brian Mauney, Director Relations | ||
Amy Brady, Chief Information Officer, Executive Officer | ||
Don Graves, Senior Director - Corporate Community Initiatives and Relations | ||
Barbara Snyder, Independent Director | ||
Kristen Manos, Independent Director | ||
William Gisel, Independent Director | ||
Craig Beazer, General Counsel, Executive Officer | ||
James JD, General Secretary | ||
William Hartmann, Chief Risk Officer, Member Executive Council and Member of Enterprise Risk Management Committee | ||
Gwen Robinson, Director of CRA Data and Compliance | ||
Edward Burke, Member Executive Council and Co-President of Key Community Bank, Commercial and Private Bank | ||
Carlton Highsmith, Independent Director | ||
Richard Tobin, Independent Director | ||
Brian Fishel, Chief Human Resource Officer, Executive Officer | ||
Douglas Schosser, Chief Accounting Officer, Executive Officer | ||
Susan Donlan, Chief Officer | ||
Gary Crosby, Director | ||
Clark Khayat, Chief Strategy Officer, Executive Officer | ||
Mark Midkiff, Chief Risk Officer, Executive Officer | ||
Trina Evans, Director of Corporate Center, Executive Officer | ||
Craig Buffie, Chief HR Officer and Member of Executive Council | ||
Richard Hipple, Independent Director | ||
Kenneth Gavrity, Head of Enterprise Payments and Executive Officer | ||
Andrew Paine, Head of Institutional Bank, Executive Officer | ||
Todd Vasos, Independent Director | ||
Kim Manigault, Chief Diversity and Inclusion Officer | ||
Robin Hayes, Independent Director | ||
Eric Fiala, Head of Corporate Responsibility | ||
Beth Mooney, Chairman, CEO, Member of Executive Council, Chairman of Executive Committee and Chairman of Enterprise Risk Management Committee | ||
Douglas CPA, Chief Officer | ||
Austin Adams, Director | ||
Robert DeAngelis, Director of the Enterprise Program Management Office | ||
Charles Cooley, Independent Director | ||
Bruce Broussard, Independent Director | ||
Stacy Gilbert, Chief Controller | ||
Donald Kimble, Vice Chairman, Chief Financial Officer, Chief Administrative Officer | ||
Andrew III, Head Bank | ||
Ruth Gillis, Independent Director | ||
Kevin Ryan, Chief Risk Officer, Executive Officer, Chief Risk Review Officer and General Auditor | ||
James Waters, General Counsel, Executive Officer, Company Secretary | ||
Amy Carlson, Executive Structuring | ||
James Warder, Chief Officer | ||
Paul Harris, General Counsel, Executive Officer, Secretary | ||
Demos Parneros, Independent Director | ||
Jaime Warder, Head of Digital Banking and Executive Officer | ||
Victor Alexander, Head of Consumer Bank, Executive Officer |
KeyCorp Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is KeyCorp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0686 | |||
Return On Asset | 0.0051 | |||
Profit Margin | 0.16 % | |||
Operating Margin | 0.1 % | |||
Current Valuation | 39.49 B | |||
Shares Outstanding | 927.47 M | |||
Shares Owned By Insiders | 0.36 % | |||
Shares Owned By Institutions | 82.20 % | |||
Number Of Shares Shorted | 26.59 M | |||
Price To Earning | 10.76 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in KeyCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy KeyCorp Stock please use our How to Invest in KeyCorp guide.Note that the KeyCorp information on this page should be used as a complementary analysis to other KeyCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for KeyCorp Stock analysis
When running KeyCorp's price analysis, check to measure KeyCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KeyCorp is operating at the current time. Most of KeyCorp's value examination focuses on studying past and present price action to predict the probability of KeyCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KeyCorp's price. Additionally, you may evaluate how the addition of KeyCorp to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is KeyCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of KeyCorp. If investors know KeyCorp will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about KeyCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.92) | Dividend Share 0.82 | Earnings Share 0.88 | Revenue Per Share 6.357 | Quarterly Revenue Growth (0.12) |
The market value of KeyCorp is measured differently than its book value, which is the value of KeyCorp that is recorded on the company's balance sheet. Investors also form their own opinion of KeyCorp's value that differs from its market value or its book value, called intrinsic value, which is KeyCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because KeyCorp's market value can be influenced by many factors that don't directly affect KeyCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between KeyCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if KeyCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, KeyCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.